Euan Ashley BSc (Hons), MB ChB, MRCP, DPhil, FACC, FAHA Associate Professor of Medicine (Cardiovascular), Director, Stanford Center for Inherited Cardiovascular Disease Co-Director, Training Program in Myocardial BiologyMember, Institute of Medicine Roundtable on Translating Genomic-based Research for Health Director, Stanford Cardiopulmonary Exercise Testing Laboratory Leadership committee, AHA Council on Functional Genomics and Translational Biology Director, [...]
Vincent has more than 30 years of management experience in the biotechnology industry, including over 15 years in Business Development in BioPharmaceuticals. He identifies and invests in new businesses and supports portfolio companies. Vincent is on the boards of Dynex Technologies, Hydra Biosciences, Magellan Diagnostics and Personalis, and has also served on the boards of [...]
Ken Ludlum is Chairman of the Audit Committee at Personalis and serves as Chief Financial Officer of CareDx, Inc., a molecular diagnostics company. Since April 2019 Mr. Ludlum has served on the board of directors and as Chairman of the Audit Committee of Dermavant Sciences Limited, a United Kingdom company. Ken led the initial public [...]
Patrick Balthrop is the founding principal of Apalachee Ventures. He has over 30 years of experience building, growing and optimizing businesses in the healthcare sector, particularly in the life sciences segments of diagnostics, life science tools and medical devices.Previously, Pat was CEO, President and Director of Luminex Corporation, a publicly-traded diagnostics, tools and devices company. [...]
Russ Biagio Altman is Professor of Bioengineering, Genetics, & Medicine (and of Computer Science, by courtesy) and former Chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing technology to basic molecular biological problems of relevance to medicine. He is particularly interested in informatics methods for advancing [...]
Carol J. Tillis joined Personalis in November 2011 with over 20 years of experience in senior financial management, much of it related to DNA sequencing. From 2004 to 2010, she was Vice President of Finance at Pacific Biosciences, Inc. Ms. Tillis started at Pacific Biosciences as its first full-time finance person during the company’s early [...]
Jonathan MacQuitty, former partner at Abingworth, has more than 15 years of operational experience in life science companies, and 12 years of venture capital experience. His directorships have included Adiana, Dicerna, Entelos, Guava, Gynesonics, Iconix, Labcyte, ParAllele BioScience, Personalis, SFJ Pharma and Sunesis Pharmaceuticals. He joined Abingworth in 1999 as President and Director of the [...]
Rena McClory joined Personalis in 2014, and serves as Vice President, Marketing, where she established and leads marketing and product management teams in building brands and accelerating product adoption in key immune-oncology, basic research and clinical markets. She was promoted from Senior Director, Cancer Research and Clinical Services in 2015. Rena brings over 20 years [...]
Dr. Haudenschild joined Personalis in early 2012 to build the company’s professional services department. Prior to this role he was an Associate Director in charge of commercial sequencing at Illumina Inc. in Hayward, California. His team was responsible for the preparation and next-generation sequencing of thousands of DNA and RNA samples. Dr. Haudenschild was previously [...]
Michael Fitzpatrick joined Personalis in April 2013 as Vice President of Worldwide Sales. During Mike’s 30 year career in the biotech field, he has built commercial teams focused primarily in the genomics space. He spent 20 years at Applied Biosystems where he held executive level positions including Vice President of The Americas, Vice President of [...]
